Background: Currently, there is little information concerning
periprosthetic humeral fractures after shoulder arthroplasty. Therefore, we
reviewed our experience with these fractures to determine the results of
treatment, the risk factors for periprosthetic fracture, and the rates of
reoperation.
Methods: Between 1976 and 2001, nineteen postoperative
periprosthetic humeral fractures occurred among 3091 patients who had
undergone shoulder arthroplasty at our institution. Sixteen patients had a
complete series of radiographs and were included in this study. The average
time from the arthroplasty to the fracture was forty-nine months. Seven
patients had severe osteopenia. Twelve fractures occurred at the tip of the
prosthesis; of these, six extended proximally (type-A fractures) and six did
not (type-B fractures). Three fractures occurred distal to the implant and
extended into the distal humeral metaphysis (type-C fractures). One fracture
occurred in the proximal metadiaphyseal region because of osteolysis.
Results: Six fractures healed after an average of 180 days of
nonoperative treatment. Five fractures were treated operatively after an
average of 123 days of unsuccessful nonoperative treatment. The remaining five
fractures had immediate operative treatment. All sixteen fractures healed. One
patient required multiple operations over a period of three years before union
was achieved. With the exclusion of this patient and one other patient who
received a custom prosthesis, the average time between the first operative
procedure and union was 278 days.
Conclusions: Our data do not clearly indicate the need for operative
treatment of type-A fractures unless the humeral component is loose. A trial
of nonoperative treatment may be considered for well-aligned type-B fractures
that are associated with a well-fixed humeral component; however, operative
intervention should be considered for type-B fractures that have not
progressed toward union by three months. If the component is well fixed, open
reduction and internal fixation may be performed. If the component is loose,
revision with a long-stem component is recommended. For type-C fractures, a
trial of nonoperative treatment is recommended.
Level of Evidence: Therapeutic study, Level IV (case
series [no, or historical, control group]). See Instructions to Authors for a
complete description of levels of evidence.